Perianesthetic Management of Laparoscopic Kidney Surgery

Nasrallah, Georges; Souki, Fouad G.

doi:10.1007/s11934-018-0757-4

Cited by 24 publications

(18 citation statements)

References 87 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Various interventions to prevent acute pain after laparoscopic donor nephrectomy have been described, but their effect on chronic pain has yet to be clarified fully. Perioperative administration of an α 2 agonist (such as clonidine), lidocaine infusion, pregabalin or ketamine have all been described as effective methods for reducing acute postoperative pain and the need for opioid medication. Effective intraoperative interventions are subfascial administration of bupivacaine, transversus abdominis plane block, low‐pressure pneumoperitoneum and deep neuromuscular blockade.…”

Section: Discussionmentioning

confidence: 99%

Chronic pain after hand-assisted laparoscopic donor nephrectomy

Zorgdrager

Londen

Westenberg

et al. 2019

British Journal of Surgery

View full text Add to dashboard Cite

Background Data on chronic pain after kidney donation are sparse. The aim of this study was to assess the incidence of chronic pain after hand‐assisted laparoscopic nephrectomy. Methods Living kidney donors who donated between 2011 and 2017 at the University Medical Centre Groningen were included. All patients underwent hand‐assisted laparoscopic donor nephrectomy. Postdonation pain and movement disabilities were assessed using the Carolinas Comfort Scale (CCS) and a visual analogue scale (VAS). The prevalence, severity of pain and the need for analgesics were reported. Results Some 333 living kidney donors with a mean age of 56 years were included. At a median of 19 (i.q.r. 10–33) months after donation, 82 donors (24·6 per cent) had a CCS score above 0, of which 58 (71 per cent) had a CCS score of at least 2 and 57 (70 per cent) reported movement limitations. Some 110 donors (33·0 per cent) had a VAS score of more than 0. Complaints mainly occurred during bending over (12·3 per cent) and exercising (12·4 per cent). Thirty‐two donors (9·7 per cent) required analgesics during follow‐up between donation and the time of measurement, and six of 82 (7 per cent) reported chronic inguinal pain. In multivariable analysis, donor age (odds ratio (OR) 0·97, 95 per cent c.i. 0·95 to 0·99; P = 0·020) and length of hospital stay (OR 1·21, 1·01 to 1·51; P = 0·041) were independently associated with chronic pain. Conclusion One‐quarter of donors experienced chronic postdonation pain or discomfort, most of which was bothersome. Younger donors and those with a longer postoperative hospital stay had more symptoms.

show abstract

Section: Discussionmentioning

confidence: 99%

Chronic pain after hand-assisted laparoscopic donor nephrectomy

Zorgdrager

Londen

Westenberg

et al. 2019

British Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Others found no increased risk of cancer recurrence after TRT post-radiation therapy for prostate cancer [14-15]. A review of the literature on the use of TRT post-treatment for prostate cancer demonstrated generally no significant increases in PSA or recurrence rate [16]. However, there is a lack of randomized controlled studies or studies with large sample sizes.…”

Section: Discussionmentioning

confidence: 99%

Prostate Cancer, Gender Identity, and Testosterone Replacement Therapy in Klinefelter Syndrome: A Case Report and Literature Review

Nishikawa

Jia

Dharamshi

et al. 2019

Cureus

View full text Add to dashboard Cite

Klinefelter syndrome (KS), karyotype 47, XXY, is a common cause of hypogonadism in males. Patients with this condition often experience symptoms of gonadal failure, which can precipitate gender identity challenges. Treatment with testosterone replacement therapy (TRT) can combat these symptoms by improving sexual function, muscle mass, bone health, and virilization, thereby enhancing the quality of life (QOL). Although TRT is often employed in patients with KS, there is a concern that the application of exogenous testosterone may increase the risk of prostate adenocarcinoma development and progression. We report the case of a 58-year-old male with KS who is also diagnosed with prostate adenocarcinoma and wished to remain on TRT post-radiation therapy in support of his gender identity and QOL. We describe the challenges this patient faced when balancing a rising prostate-specific antigen level and risk of cancer recurrence with his QOL.

show abstract

“…Combinations of these operation modes (e.g. “pop-dusting”) also represent additional clinical options [ 5 ]. These major modes are briefly summarized in Table 3…”

Section: Holmium:yag Laser Lithotripsy (λ = 2120 Nm)mentioning

confidence: 99%

Recent advances in infrared laser lithotripsy [Invited]

Fried

2018

Biomed. Opt. Express

118

View full text Add to dashboard Cite

The flashlamp-pumped, solid-state, pulsed, mid-infrared, holmium:YAG laser (λ = 2120 nm) has been the clinical gold standard laser for lithotripsy for over the past two decades. However, while the holmium laser is the dominant laser technology in ureteroscopy because it efficiently ablates all urinary stone types, this mature laser technology has several fundamental limitations. Alternative, mid-IR laser technologies, including a thulium fiber laser (λ = 1908 and 1940 nm), a thulium:YAG laser (λ = 2010 nm), and an erbium:YAG laser (λ = 2940 nm) have also been explored for lithotripsy. The capabilities and limitations of these mid-IR lasers are reviewed in the context of the quest for an ideal laser lithotripsy system capable of providing both rapid and safe ablation of urinary stones.

show abstract

Perianesthetic Management of Laparoscopic Kidney Surgery

Cited by 24 publications

References 87 publications

Chronic pain after hand-assisted laparoscopic donor nephrectomy

Chronic pain after hand-assisted laparoscopic donor nephrectomy

Prostate Cancer, Gender Identity, and Testosterone Replacement Therapy in Klinefelter Syndrome: A Case Report and Literature Review

Recent advances in infrared laser lithotripsy [Invited]

Contact Info

Product

Resources

About